Dr. Amir Kol realized the striking parallels between FIP and severe COVID-19 could offer hope for millions of long COVID ...

And this presents a unique challenge because we don't have any diagnostic tests that we can say, hey, you definitively have long COVID. It really requires a long and extensive and rather expensive ...

For many, COVID-19 has become a distant memory. But for Patricia Hill, it’s an ongoing battle—one that has reshaped her life in ways she never imagined.

Everyone who gets a COVID-19 infection is at potential risk for developing long COVID. It’s important to emphasize, especially as we are still living with this virus, that there’s a new risk of ...

When patients feel heard and believed, they become more open to psychological tools—not as a cure, but as a way to cope with uncertainty, identity disruption, and the daily challenges of Long Covid.

Long Covid is known to cause over 200 different symptoms in nearly a dozen organ systems, including those of the heart, ... The challenge now is finding one or more biomarkers — genes, ...

Long COVID by contrast has emerged among working-age adults, Ikramuddin said, ... Doctors have reported challenges in diagnosing and treating long COVID, ...

Q&A with a researcher fighting long COVID and searching for ... she took time to discuss the challenges experienced daily by those who continue to experience severe symptoms months or even ...

ALBANY – As with the 1918 Spanish flu, the most lethal pandemic in recorded world history, the 2020 Covid-19 health crisis promises to bring sweeping changes and improvements in public health in ...

Long COVID linked to lasting physical and mental health challenges, study finds—vaccination offers protective benefits. Study: Differences in Long COVID severity by duration of illness, symptom ...

On Sunday, Feb. 16 at 6 p.m., KETV will air its hour-long documentary, "COVID-19: Life After the Pandemic," which highlights everything from the medical communities' memories of the pandemic, to ...

Use of donepezil (Aricept), an acetylcholinesterase inhibitor, for 3 weeks failed to demonstrate efficacy in treating fatigue and psychological symptoms of long COVID in a randomized trial from Japan.